2019
Preference Phenotypes in Support of Shared Decision–Making at Point‐of‐Care for Patients With Rheumatoid Arthritis: A Proof‐of‐Concept Study
Hsiao B, Binder‐Finnema P, Nowell W, Michel G, Wiedmeyer C, Fraenkel L. Preference Phenotypes in Support of Shared Decision–Making at Point‐of‐Care for Patients With Rheumatoid Arthritis: A Proof‐of‐Concept Study. Arthritis Care & Research 2019, 71: 629-637. PMID: 29953733, PMCID: PMC6310675, DOI: 10.1002/acr.23684.Peer-Reviewed Original ResearchConceptsDisease-modifying antirheumatic drugsNew disease-modifying antirheumatic drugsValues clarification toolPost-test visitsMore disease-modifying antirheumatic drugsTest visitsPretest/post-test studyAntirheumatic drugsMore patientsOutpatient visitsRheumatoid arthritisConcept studyPost-test studyPatientsPatient valuesSD lengthPost-test phaseVisitsActive RAVisit timeCarePretest phaseEscalation decisionsPreference phenotypesPhenotype
2017
Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis
Fraenkel L, Nowell WB, Michel G, Wiedmeyer C. Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis. Annals Of The Rheumatic Diseases 2017, 77: 678. PMID: 29247126, PMCID: PMC5898982, DOI: 10.1136/annrheumdis-2017-212407.Peer-Reviewed Original ResearchConceptsBothersome side effectsRare side effectRheumatoid arthritisSide effectsSerious infectionsOnset of actionJanus kinase inhibitorPreferences of patientsMethotrexate monotherapyTriple therapyParenteral medicationsPoint of careTreatment preferencesGroup 2Patient valuesPatientsGroup 4Target strategyGroup 5Kinase inhibitorsConjoint analysis surveyLatent class analysisLarge groupArthritisMedications